Roche Holding | ROG - Interest Expense On Debt



Roche Holding reported CHF311.5M in Interest Expense on Debt for its fiscal semester ending in December of 2024.


Interest Expense On Debt Change Date
AbbVie USD 700M 90M Mar/2025
Alcon AG USD 49M 1000K Mar/2025
Amgen USD 694M 29M Jun/2025
AstraZeneca 303M 126M Jun/2025
Bayer 495M 89M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 485M 9M Jun/2025
Eli Lilly USD 249M 5.3M Jun/2025
Fresenius 86M 30M Jun/2025
Fresenius Medical Care EUR 96.58M 15.58M Jun/2025
Galapagos EUR 780K 49.34M Mar/2025
Genmab DKK 9M 4M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical 22M 9M Jun/2024
Lonza CHF 70M 11M Dec/2024
Merck 79M 1000K Jun/2025
Merck USD 305M 8M Jun/2025
Novartis USD 289M 19M Jun/2025
Orion 1.2M 200K Jun/2025
Pfizer USD 654M 0 Jun/2025
Philips 80M 24M Jun/2025
Recordati EUR 24.49M 6.41M Jun/2025
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025
UCB 108M 16M Dec/2024